Home Talking Numbers – CNBC | This Chart Spells Trouble for Pfizer

Talking Numbers – CNBC | This Chart Spells Trouble for Pfizer

Avatar
written by hierophant Tuesday, June 24, 2014

Pfizer shares are down nearly 9% in the past 3 months and severely lagging the broader market. Watch the video to find out if The Oxford Club’s Marc Lichtenfeld and Carter Worth of Sterne Agee think this stock is going to recover anytime soon.

Get Wealthy Retirement
in Your Email Inbox

Get access to all of the retirement secrets and income strategies from our experts!

By submitting your email address, you will receive a free subscription to Wealthy Retirement, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Newsletter FAQs | privacy policy